As endpoint of cohort studies on cancer, the incidence, rather than the mortality is preferable, if risk factors have been assessed with regard to cancer development. Many cohort studies make use of existing routine surveillance systems of the incidence of cancer, such as population-based cancer registries, to ascertain the outcome of interest.
the subjects dead who died from cancer, and the subjects with incident cancer during the periods of observation by sex according to area in Table 2 . The proportions of cancer deaths among total deaths varied from 22.4% to 54.7% among the male subjects, and from 14.3% to 71.4% among the female subjects as shown in Table 2 .
Completeness of survey for incidence of cancer is defined as the extent to which all the incident cancers occurring in a target population are included for the study subjects. 4, 5 Ideally, completeness should be close to 100%, so that comparison of rates among areas will reflects true differences in the risk of cancer and not artifacts of the survey process. Generally, however, most ASI would have the possibility of incompleteness due to failure to identify and include incident cancers. Completeness is assessed by measuring the percentage of the subjects with cancer identified from the death certificate only (DCO%), the percentage of the subjects with cancer first notified via death certificate (DCN%), and the mortality/incidence ratio (MI ratio). Although the DCO% and the DCN% could not be estimated because of lack in relevant information, the MI ratio was evaluated as shown in Table 2 .
If the MI ratio exceeds 0.70, it is usually a signal of under-registration 5 of incident cancers. As shown in Table 2 , where a population-based cancer registry was utilized, the MI ratio deviated from 0.31 to 0.61 in the male subjects and from 0.15 to 0.53 in the female subjects. However, where a population-based cancer registry was not used, the MI ratio deviated from 0.25 to 0.72 in the male subjects and from 0.13 to 0.79 in the female subjects, and there was an area where the MI ratio exceeded 0.70 in both of the male and female subjects.
Our entire study design, which comprised singular and collective use of epidemiologic data and biological materials (serum only), was approved in 2000 by the Ethical Board at Nagoya University School of Medicine, where the central secretariat of the JACC study is located.
Areas and tools of survey for incidence of cancer Of 45 areas in the JACC Study, surveys for incidence of cancer were conducted in 24. Among them, 10 areas were located in the same prefecture in Kyushu, and were surveyed by the same institution, utilizing a population-based cancer registry. Consequently, we combined these 10 areas, and present the data of 15 ASI unified from the 24 ASI by gender according to area in Table 1 . The proportion of the study subjects aged 40 to 79 years in the ASI (65,184 persons) was 58.8% among them in the JACC Study (110,792 persons).
As tools to survey for cancer incidence, population-based cancer registries were utilized in 11 out of the 15 ASI, and hospitalbased cancer registries or inpatients' records of hospitals treating cancer patients were used in the remaining 4 ASI. Although the tentative end of observation was in 1997 in 14 of the 15 ASI for this article, it was in 1994 in an area because of incidental interruption in the survey for cancer incidence, as shown in Table 1 . Table 1 also shows the number of subjects, aged 40 to 79 years at the baseline survey.
Incidence of cancer and completeness of survey
Excluding the subjects who had cancer before the baseline survey, we present the numbers of the study subjects, the dead subjects, P2  P3  P4  P5  P6  P7  P8  P9  P10  P11  O1  O2  O3  O4  Total  Table 2 . Number of subjects with cancer and mortality/incidence ratio for cancer incidence by gender according to area, aged 40 to 79 years at the baseline survey, excluding subjects who had cancer before the baseline survey. P1  P2  P3  P4  P5  P6  P7  P8  P9  P10  P11  O1  O2  O3  O4  Table 3 . Crude and age-adjusted rates of incidence and mortality of cancer by gender according to area among subjects aged 40 to 79 years at the baseline survey, excluding subjects who had cancer before the baseline survey.
Male Female * : Population-based cancer registries were utilized for areas from P1 to P11, but hospital-based cancer registries or inpatients' records of hospitals treating cancer patients were used for areas from O1 to O4. 58.2% of the study subjects were involved in the ASI of the JACC Study, and considerable variations were observed in the MI ratio of the survey for incidence. Therefore, the findings from the results of analysis of the subjects with incident cancer should be reported with the MI ratio of Table 2 . Furthermore, establishment of population-based cancer registries is strongly desired throughout Japan to assess risk factors of cancer development for primary prevention of cancer.
